Biotechnology News

July 30, 2014

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the second quarter ended June 30,...

July 30, 2014

KUALA LUMPUR, Malaysia--(BUSINESS WIRE)--The Republic of Guinea is looking up to Malaysia’s expertise in the palm oil sector to boost the two nations’ bilateral trade ties, which was valued at US$45 million (RM143.10 million) last year, and the...

July 29, 2014

MADISON, Wis.--(BUSINESS WIRE)--NIH awards Imbed Bio a $1.5M grant to continue development of an advanced wound healing nanofilm dressing with silver nanoparticles that provides antimicrobial barrier in burns and chronic ulcers.

July 29, 2014

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. launches $40 million offering.

July 29, 2014

BOSTON--(BUSINESS WIRE)--Vertex Reports Second Quarter 2014 Financial Results and Provides Updates on Key Research and Development Programs

July 29, 2014

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) today announced financial results for the second quarter ended June 30, 2014. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and...

July 29, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Vantage Health (the “Company”) (OTCQB:VNTH) today announced the appointment of Kevin Buckman MD FAAIM, DAAUCM, MACOEM, MRO as Chairman and CEO of the Company. The Company also announced that Mr. Jeremy...

July 29, 2014

CHICAGO--(BUSINESS WIRE)--Fitch Ratings expects that revenues from biologic therapies as a percentage of total pharmaceutical sales will continue to increase over the intermediate term as companies increase their prominence in their drug...

July 29, 2014

WITTEN, Germany--(BUSINESS WIRE)--SanguiBioTech yields revenues of around USD42,000 in Q4 2014 according to preliminary figures

July 29, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Paris:MKEA) (NYSE Euronext: MKEA, FR0010609263), a leader in the optical biopsy market, announced today it has received 501(k) regulatory clearance from the United States Food and...

July 29, 2014

SAN MATEO, Calif.--(BUSINESS WIRE)--SmartStory™ Technologies announced it has deployed its groundbreaking SmartStory enterprise platform.

July 29, 2014

PHILADELPHIA--(BUSINESS WIRE)--Revitas Welcomes Cumberland Consulting Group as the Exclusive Diamond Sponsor for the 2014 Revitas Industry Summit: Life Sciences

July 29, 2014

PHOENIX--(BUSINESS WIRE)--Creative Medical Health, a biotechnology and bionutraceutical company, announces trademark approval in the U.S. and E.U. for its designation Bionutraceutical.

July 29, 2014

SUFFERN, N.Y.--(BUSINESS WIRE)--Genomics R&D firm, Ryogen LLC, received two U.S. Patents – its 31st and 32nd – that are directed to polynucleotide sequences that play critical roles in various cancers.

July 29, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--MolecularHealth Expands U.S. Sales Team with Three Strategic New Hires

July 29, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea will report its financial results for the second quarter 2014, on Wednesday, August 6, 2014 before the market opens followed by a conference call with the investment community at 8:30 AM EDT.

July 29, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--SunTech Medical, the global leader in clinical-grade, non-invasive blood pressure measurement solutions, has acquired King’s College London’s central blood pressure technology as well as the assets of Centron...

July 29, 2014

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central...

July 29, 2014

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--23andMe has received from the NIH a grant totaling $1,367,504 for a two-year project to support the further development of 23andMe’s web-based database and research engine for genetic discovery.

July 29, 2014

MILAN--(BUSINESS WIRE)--Sorin Group gets U.S. FDA approval for Solo Smart, the first aortic valve with a removable stent that provides native-like performance with the ease of implant of a stented valve.

July 29, 2014

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jin-En International Group Holding Co. (“Jin-en” or “the Company”) (PINK.BB: JINZ), is pleased to announce the acquisition 100% of the outstanding shares of Nascent Biotech Inc., a Nevada corporation (“NBI...

July 29, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Abbie Celniker, Ph.D., President and CEO of Eleven Biotherapeutics, to present at the Wedbush 2014 Life Sciences Management Access Conference in NY on Tuesday, August 12, 2014 at 2:30 p.m. ET

July 29, 2014

WOBURN, Mass.--(BUSINESS WIRE)--ArQule announces date and time of Q2 2014 financial results reporting.

July 29, 2014

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (Nasdaq:NPSP) announced today that it will report its second 2014 financial results on Wednesday, August 6, 2014 at approximately 4:30 p.m. ET. The press release will be followed by a...

July 29, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it has added three new events to its series of online “RNAi Roundtables” that it is hosting during July and...

July 29, 2014

ATLANTA--(BUSINESS WIRE)--Amniox Medical, Inc., a developer and marketer of restorative therapies processed from amniotic membrane and umbilical cord, announces the initiation of a randomized, controlled clinical trial of its proprietary product...

July 29, 2014

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) announced today that U.S. District Judge Leonard P. Stark has established August 18th as the date for a patent claim construction hearing, also called a Markman hearing, involving Enzo Life...

July 29, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) today announced financial results for the fiscal year ended April 30, 2014, and provided a corporate update.

July 29, 2014

LA JOLLA, Calif.--(BUSINESS WIRE)--Intrinsic LifeSciences has been awarded a $4.45M grant from NIH to fund a study to clinically validate the Hepcidin Index test for the differential diagnosis of Iron Refractory Iron Deficiency Anemia

July 29, 2014

NEW YORK--(BUSINESS WIRE)--Ophthotech Corporation (Nasdaq: OPHT) today announced that it will release its financial results for the second quarter ended June 30, 2014, on Wednesday, August 6, 2014.

July 29, 2014

SEATTLE & CHICAGO--(BUSINESS WIRE)--Nanostring has expanded the capabilities of its nCounter Elements™ General Purpose Reagents (GPRs) to offer specific detection and analysis of known fusion genes.

July 29, 2014

FRAMINGHAM, Mass.--(BUSINESS WIRE)--AB SCIEX today confirmed its commitment to support the diagnostic market with the unveiling of the Triple Quad™ 4500MD and QTRAP® 4500MD LC/MS/MS systems under its SCIEX Diagnostics brand.

July 29, 2014

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen will host a conference call at 10:00 AM EDT on Tuesday, August 5, 2014 to review the second quarter 2014 results. Results will be on the Company’s website prior to the conference call.

July 29, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) reported financial results for second-quarter 2014. At the beginning of fiscal year 2014, the company began managing its commercial operations through a new global commercial structure consisting...

July 29, 2014

SEATTLE & NEW YORK--(BUSINESS WIRE)--Accelerator Corporation Secures $51.1 Million to
Support Emerging Biotechnology Research Opportunities in New York City and Seattle

July 29, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ: FMI) today announced the launch of an updated FoundationOne®, incorporating several enhancements that reflect the company’s ongoing commitment to innovation in patient care....

July 29, 2014

PARIS--(BUSINESS WIRE)--Cellectis sells its Swedish subsidiary, Cellectis AB, to the Japanese company Takara Bio Inc.

July 29, 2014

TORONTO--(BUSINESS WIRE)--ANTIBE THERAPEUTICS REPORTS YEAR-END FINANCIAL AND OPERATING RESULTS

July 28, 2014

CHICAGO--(BUSINESS WIRE)--The 2014 American Association for Clinical Chemistry (AACC) today awarded Sony DADC BioSciences and Taiwan Semiconductor Manufacturing Co. Ltd. (TSMC) with its Best Abstract of Interest to the Industry Division Award....

July 28, 2014

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company advancing NNR Therapeutics™, today announced top-line results from a Phase 2b clinical trial of TC-5214 as a treatment for overactive...

July 28, 2014

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced positive preliminary second quarter 2014 results and an update on its...

July 28, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--diaDexus, Inc. (OTCQB: DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced financial results for the second quarter ended June 30, 2014. "We...

July 28, 2014

SALT LAKE CITY--(BUSINESS WIRE)--BioFire Diagnostics, LLC, bioMérieux’s molecular biology affiliate, today announced that it has recently signed a new purchasing agreement with HealthTrust to provide multi-target molecular diagnostics tests for...

July 28, 2014

LYON, France--(BUSINESS WIRE)--Regulatory News: ERYTECH Pharma (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology...

July 28, 2014

BEIJING--(BUSINESS WIRE)--CANbridge Life Sciences and EUSA Pharma, a subsidiary of Jazz Pharmaceuticals, have entered into a partnership to develop EUSA's Caphosol treatment in China for the treatment of chemo side effects.

July 28, 2014

LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma and the United States Army announce the initiation of a clinical trial for the use of Theramine for the treatment of low back pain among active service members.